what is the equivalent dose of semaglutide to tirzepatide & Dosing Guide: mg Units Chart Switching from Semaglutide to Tirzepatide

We therefore conclude that before the place of GLP-1/glucagon co-agonists within the therapeutic armamentarium can be defined, future research efforts need to address the following outstanding questions: What is the optimal balance and receptor potency of GLP-1 and glucagon in a long-acting co-agonist, to minimise adverse effects and to optimise efficacy ( Figure 2 )

Gentler, it works with your bodys rhythm and supports long-term balance

J.SamsonW

Common side effects from Phase 2 data include nausea, vomiting, diarrhoea, and constipation, consistent with the GLP-1 receptor agonist drug class

Profound nausea can lead to severe under-eating, where patients struggle to consume even basic nutrients